Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

198 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The decline of anti-drug antibody titres after discontinuation of anti-TNFs: implications for predicting re-induction outcome in IBD.
Ben-Horin S, Mazor Y, Yanai H, Ron Y, Kopylov U, Yavzori M, Picard O, Fudim E, Maor Y, Lahat A, Coscas D, Eliakim R, Dotan I, Chowers Y. Ben-Horin S, et al. Among authors: chowers y. Aliment Pharmacol Ther. 2012 Mar;35(6):714-22. doi: 10.1111/j.1365-2036.2012.04997.x. Epub 2012 Jan 30. Aliment Pharmacol Ther. 2012. PMID: 22288419 Free article.
Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitis.
Ungar B, Mazor Y, Weisshof R, Yanai H, Ron Y, Goren I, Waizbard A, Yavzori M, Fudim E, Picard O, Loebstein R, Kopylov U, Dotan I, Chowers Y, Eliakim R, Ben-Horin S. Ungar B, et al. Among authors: chowers y. Aliment Pharmacol Ther. 2016 Jun;43(12):1293-9. doi: 10.1111/apt.13631. Epub 2016 Apr 19. Aliment Pharmacol Ther. 2016. PMID: 27091119 Free article.
Is Super-Selective Superior?
Waterman M, Kurnik D, Chowers Y. Waterman M, et al. Among authors: chowers y. J Crohns Colitis. 2016 Oct;10(10):1129-31. doi: 10.1093/ecco-jcc/jjw128. Epub 2016 Jul 11. J Crohns Colitis. 2016. PMID: 27402914 No abstract available.
Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab.
Ungar B, Kopylov U, Engel T, Yavzori M, Fudim E, Picard O, Lang A, Williet N, Paul S, Chowers Y, Bar-Gil Shitrit A, Eliakim R, Ben-Horin S, Roblin X. Ungar B, et al. Among authors: chowers y. Aliment Pharmacol Ther. 2017 Jan;45(2):276-282. doi: 10.1111/apt.13862. Epub 2016 Nov 16. Aliment Pharmacol Ther. 2017. PMID: 27862102 Free article.
198 results